Postoperatively, HBsAg and HBsAb titers were measured every other day until the patient became HBsAg negative and HBsAb positive. After discharge from the hospital, patients were reviewed in the ...
In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...
Inside the hepatocytes, HBV produces a surplus of viral antigens, including hepatitis B e antigen (HBeAg) and hepatitis B s antigen (HBsAg), which is HBV’s envelope protein. In addition to the ...
“Functional cure — defined as a sustained loss of HBsAg and undetectable HBV DNA at 24 weeks after finite-duration therapy — is a desired treatment outcome that is associated with ...
positive or negative, chronic hepatitis B patients who are currently on nucleos(t)ide antiviral therapy and have HBV DNA levels below 40IU/mL and HBsAg levels under 500IU/mL. Virion dosed the ...